Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Incidence and Epidemiological study of COVID-19 in Nagpur urban region (India) using Molecular testing

Jay Tanna, Bishwadeep Singha, Amit R. Nayak, Aliabbas A. Husain, Dhananjay V. Raje, Shubhangi A. Desai, Madhavi Deshmukh, Shailendra Mundhada, Rajpal S Kashyap
doi: https://doi.org/10.1101/2021.05.11.21256719
Jay Tanna
1Dhruv Pathology and Molecular Diagnostic Lab, Central Bazar road, Nagpur-440022, Maharashtra, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bishwadeep Singha
2Research Center, Dr. G.M Taori Central India Institute of Medical Sciences (CIIMS), 88/2 Bajaj Nagar, Nagpur-440010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit R. Nayak
2Research Center, Dr. G.M Taori Central India Institute of Medical Sciences (CIIMS), 88/2 Bajaj Nagar, Nagpur-440010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aliabbas A. Husain
2Research Center, Dr. G.M Taori Central India Institute of Medical Sciences (CIIMS), 88/2 Bajaj Nagar, Nagpur-440010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dhananjay V. Raje
2Research Center, Dr. G.M Taori Central India Institute of Medical Sciences (CIIMS), 88/2 Bajaj Nagar, Nagpur-440010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shubhangi A. Desai
2Research Center, Dr. G.M Taori Central India Institute of Medical Sciences (CIIMS), 88/2 Bajaj Nagar, Nagpur-440010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhavi Deshmukh
1Dhruv Pathology and Molecular Diagnostic Lab, Central Bazar road, Nagpur-440022, Maharashtra, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shailendra Mundhada
1Dhruv Pathology and Molecular Diagnostic Lab, Central Bazar road, Nagpur-440022, Maharashtra, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dhruvlabs{at}gmail.com raj_ciims{at}rediffmail.com
Rajpal S Kashyap
2Research Center, Dr. G.M Taori Central India Institute of Medical Sciences (CIIMS), 88/2 Bajaj Nagar, Nagpur-440010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dhruvlabs{at}gmail.com raj_ciims{at}rediffmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) virus has emerged as public health emergency affecting 206 countries worldwide. India is second highest currently worst effected by Covid 19 pandemic with close to 12.6 million cases and 1.6K deaths reported till date. Maharahstra is the highest Covid-19 burden state in India reporting quarter of overall cases. The city of Nagpur, in Maharashtra state, ranks 4th in terms of reported COVID-19 cases, with 2.5 lakh incidences and more than 4,000 deaths As the transmission rate of COVID-19 is high, it is imperative to study its disease epidemiology in regions of high endemicity to bolster our understanding of its spread, transmission dynamics and contact tracing to undertake appropriate public health control measures.. The present study was undertaken to study the incidence and trend of COVID-19 infection from various zonal regions of Nagpur city, using real time PCR (RT PCR). A retrospective study was carried out at Indian Council of Medical Research (ICMR) approved private molecular diagnostic laboratory in Nagpur from period of 4th May 2020 to 14th November 2020. A total of 51,532 samples collected from various zonal regions of the city during the study period were processed for SARS CoV-2 RT-PCR. Patient information was collected using a pre-defined study proforma which included demographic details such as name, age, gender, address, along with other information, like details of sample collected, kits used and date of sample collected and processed. The study reports an overall Covid-19 positivity of 34% in Nagpur region. The zone wise distribution of positive cases indicated high rate of COVID-19 in endemic regions of Nagpur such as Satranjipura (49%), Ashi nagar (44%), Gandhibagh (43%) & Lakadganj (43%). Rates of infection were high in economically productive age group (21-40) with males being more vulnerable than females. The result of present epidemiology study highlights important data with respect to regions of endemicity within Nagpur city zones. The present data has high public health importance and will be useful for local civic bodies and other community stake holders to undertake appropriate control measures in future epidemic waves of Covid 19. Interestingly, the Government’s reduction in testing rates has been helpful in increasing testing per day. The authorization of private laboratories has also increased testing.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received for the current study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by Institutional Ethical Committee of Dr. G. M. Taori Central India Institute of Medical Sciences (CIIMS),Nagpur. Approvals to conduct RT-PCR in Human samples was provided by Indian Council of Medical Research (ICMR), Govt of India. Registration Number (DPMDLN)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

NA

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 11, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Incidence and Epidemiological study of COVID-19 in Nagpur urban region (India) using Molecular testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Incidence and Epidemiological study of COVID-19 in Nagpur urban region (India) using Molecular testing
Jay Tanna, Bishwadeep Singha, Amit R. Nayak, Aliabbas A. Husain, Dhananjay V. Raje, Shubhangi A. Desai, Madhavi Deshmukh, Shailendra Mundhada, Rajpal S Kashyap
medRxiv 2021.05.11.21256719; doi: https://doi.org/10.1101/2021.05.11.21256719
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Incidence and Epidemiological study of COVID-19 in Nagpur urban region (India) using Molecular testing
Jay Tanna, Bishwadeep Singha, Amit R. Nayak, Aliabbas A. Husain, Dhananjay V. Raje, Shubhangi A. Desai, Madhavi Deshmukh, Shailendra Mundhada, Rajpal S Kashyap
medRxiv 2021.05.11.21256719; doi: https://doi.org/10.1101/2021.05.11.21256719

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)